Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Remazolam in Gastroenteroscopy in Elderly Patients

NCT05103696 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT05103696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05103696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Remazolam in Gastroenteroscopy in Elderly Patients
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2021
Completion date
March 30, 2023
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly patients, etomidate combined with propofol, gastrointestinal endoscopy, remimazolam besylate